[1] Kong YY,Fuchsberger M, Xiang SD, et al.Myeloid derived suppressor cells and their role in diseases.Curr Med Chem,2013,20(11):1437-1444. [2] Boros P,Ochando JC,Chen SH,et al.Myeloid-derived suppressor cells:natural regulators for transplant tolerance. Hum Immunol,2010,71(11):1061-1066. [3] Talmadge JE,Gabrilovich DI.History of myeloid-derived suppressor cells. Nat Rev Cancer,2013,13(10):739-752. [4] Laoui D,Van Overmeire E,Movahedi K,et al.Mononuclear phagocyte heterogeneity in cancer: different subsets and activation states reaching out at the tumor site. Immunobiology,2011,216(11):1192-1202. [5] Serafini P,Carbley R,Noonan KA,et al.High-dose granulocyte-macrophage colony-stimulating factor-producing vaccines impair the immune response through the recruitment of myeloid suppressor cells. Cancer Res,2004,64(17):6337-6343. [6] Kowanetz M,Wu X,Lee J,et al.Granulocyte-colony stimulating factor promotes lung metastasis through mobilization of Ly6G+Ly6C+ granulocytes.Proc Natl Acad Sci U S A,2010,107(50):21248-21255. [7] Jin H,Aiyer A,Su J,et al.A homing mechanism for bone marrow-derived progenitor cell recruitment to the neovasculature.J Clin Invest,2006,116(3):652-662. [8] Delano MJ,Scumpia PO,Weinstein JS,et al.MyD88-dependent expansion of an immature GR-1(+)CD11b(+) population induces T cell suppression and Th2 polarization in sepsis. J Exp Med,2007,204(6):1463-1474. [9] Gabrilovich DI,Nagaraj S.Myeloid-derived suppressor cells as regulators of the immune system.Nat Rev Immunol,2009,9(3):162-174. [10] Gabrilovich DI,Bronte V,Chen SH,et al. The terminology issue for myeloid-derived suppressor cells. Cancer Res,2007,67(1):425;author reply 426. [11] Youn JI,Nagaraj S,Collazo M,et al.Subsets of myeloid-derived suppressor cells in tumor-bearing mice. J Immunol,2008,181(8):5791-5802. [12] Dumitru CA,Moses K,Trellakis S,et al.Neutrophils and granulocytic myeloid-derived suppressor cells:immunophenotyping,cell biology and clinical relevance in human oncology. Cancer Immunol Immunother,2012,61(8):1155-1167. [13] Rodriguez PC,Ernstoff MS,Hernandez C,et al.Arginase I-producing myeloid-derived suppressor cells in renal cell carcinoma are a subpopulation of activated granulocytes.Cancer Res,2009,69(4):1553-1560. [14] Zhao F,Hoechst B, Duffy A, et al.S100A9 a new marker for monocytic human myeloid-derived suppressor cells.Immunology,2012,136(2):176-183. [15] Mirza N, Fishman M, Fricke I, et al.All-trans-retinoic acid improves differentiation of myeloid cells and immune response in cancer patients. Cancer Res,2006,66(18):9299-9307. [16] Nagaraj S,Gupta K, Pisarev V, et al.Altered recognition of antigen is a mechanism of CD8+ T cell tolerance in cancer. Nat Med,2007,13(7):828-835. [17] Ostrand-Rosenberg S,Sinha P.Myeloid-derived suppressor cells:linking inflammation and cancer.J Immunol,2009,182(8):4499-4506. [18] Srivastava MK,Sinha P,Clements VK,et al.Myeloid-derived suppressor cells inhibit T-cell activation by depleting cystine and cysteine.Cancer Res,2010,70(1):68-77. [19] Serafini P,Mgebroff S,Noonan K,et al.Myeloid-derived suppressor cells promote cross-tolerance in B-cell lymphoma by expanding regulatory T cells.Cancer Res,2008,68(13):5439-5449. [20] Li H,Han Y,Guo Q,et al.Cancer-expanded myeloid-derived suppressor cells induce anergy of NK cells through membrane-bound TGF-beta 1.J Immunol,2009,182(1):240-249. [21] Nausch N,Galani IE,Schlecker E,et al.Mononuclear myeloid derived “suppressor” cells express RAE-1 and activate natural killer cells. Blood,2008,112(10):4080-4089. [22] Shen P,Wang A,He M,et al.Increased circulating Lin(-/low) CD33(+) HLA-DR(-) myeloid-derived suppressor cells in hepatocellular carcinoma patients. Hepatol Res,2014,44(6):639-650. [23] Xu Y,Zhao W,Xu J,et al.Activated hepatic stellate cells promote liver cancer by induction of myeloid-derived suppressor cells through cyclooxygenase-2.Oncotarget,2016,7(8):8866-8878. [24] Kapanadze T,Gamrekelashvili J,Ma C,et al.Regulation of accumulation and function of myeloid derived suppressor cells in different murine models of hepatocellular carcinoma.J Hepatol,2013,59(5):1007-1013. [25] Ma S,Cheng Q,Cai Y,et al.IL-17A produced by gammadelta T cells promotes tumor growth in hepatocellular carcinoma.Cancer Res,2014,74(7):1969-1982. [26] Hoechst B,Voigtlaender T,Ormandy L,et al.Myeloid derived suppressor cells inhibit natural killer cells in patients with hepatocellular carcinoma via the NKp30 receptor. Hepatology,2009,50(3):799-807. [27] Hoechst B,Ormandy LA,Ballmaier M,et al.A new population of myeloid-derived suppressor cells in hepatocellular carcinoma patients induces CD4(+)CD25(+)Foxp3(+)T cells.Gastroenterology,2008,135(1):234-243. [28] Arihara F,Mizukoshi E,Kitahara M,et al.Increase in CD14+ HLA-DR-/low myeloid-derived suppressor cells in hepatocellular carcinoma patients and its impact on prognosis.Cancer Immunol Immunother,2013,62(8):1421-1430. [29] Chen S,Akbar S,Abe M,et al.Immunosuppressive functions of hepatic myeloid-derived suppressor cells of normal mice and in a murine model of chronic hepatitis B virus. Clin Exp Immunol,2011,166(1):134-142. [30] Kong X,Sun R,Chen Y,et al.Gammadelta T cells drive myeloid- derived suppressor cell-mediated CD8+T cell exhaustion in hepatitis B virus-induced immunotolerance. J Immunol,2014,193(4):1645-1653. |